Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 3, 2024
OM-85 attenuates high-fat diet-induced obesity, insulin resistance, gut dysbiosis and nonalcoholic steatohepatitis in a murine modelSarah Hewady, Clarence R Manuel, Christian Pasquali, et al.
Pharmaceutics|October 27, 2022
Vaginal Nanoformulations for the Management of Preterm BirthAsad Mir, Richa V Vartak, Ketan Patel, et al.
The American Journal of Pathology|August 31, 2010
Blockade of endothelin-1 with a novel series of 1,3,6-trisubstituted-2-carboxy-quinol-4-ones controls infection-associated preterm birthNicole S Olgun, Hardik J Patel, Ralph Stephani, et al.
Experimental Lung Research|March 1, 2008
Phosphoramidon, an endothelin-converting enzyme inhibitor, attenuates lipopolysaccharide-induced acute lung injuryTapan M Bhavsar, Joseph M Cerreta, Ming Liu, et al.
Canadian Journal of Physiology and Pharmacology|September 2, 2008
Effect of the putative novel selective ETA-receptor antagonist HJP272, a 1,3,6-trisubstituted-2-carboxy-quinol-4-one, on infection-mediated premature deliveryNicole Olgun, Hardik J Patel, Ralph Stephani, et al.
Biomolecules|August 26, 2022
Palmitic Acid Impedes Extravillous Trophoblast Activity by Increasing MRP1 Expression and FunctionYunali Ashar, Qiuxu Teng, John N D Wurpel, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 2, 2025
Improving the safety of N,N-dimethylacetamide (DMA) as a potential treatment for preterm birth in a pregnant mouse model using a vaginal nanoformulationAsad Mir, Teeshavi Acosta, Marta Concheiro-Guisan, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Improving the Safety of N,N-Dimethylacetamide (DMA) as a Potential Treatment for Preterm Birth in a Pregnant Mouse Model Using a Vaginal NanoformulationAsad Mir, Teeshavi Acosta, Marta Concheiro-Guisan, et al.
Pageof 6